Table 6.
GO Enrichment and Pathway Analyses of Hub Genes
GO Term | Gene Count | P-Value |
---|---|---|
Biological process | ||
Platelet degranulation | 7 | 5.39E-10 |
Platelet activation | 5 | 4.64E-06 |
Extracellular matrix organization | 5 | 3.80E-05 |
Cell division | 5 | 3.56E-04 |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 3 | 6.29E-04 |
Platelet aggregation | 3 | 7.73E-04 |
Blood coagulation | 4 | 7.86E-04 |
Cell adhesion | 5 | 9.88E-04 |
Mitotic nuclear division | 4 | 0.002 |
Anaphase-promoting complex-dependent catabolic process | 3 | 0.003 |
Positive regulation of calcidiol 1-monooxygenase activity | 2 | 0.003 |
Sequestering of triglyceride | 2 | 0.004 |
Sister chromatid cohesion | 3 | 0.005 |
Positive regulation of fever generation | 2 | 0.005 |
Inflammatory response | 4 | 0.006 |
Regulation of establishment of endothelial barrier | 2 | 0.007 |
Positive regulation of protein phosphorylation | 3 | 0.007 |
Cytokine-mediated signaling pathway | 3 | 0.008 |
Regulation of chromosome segregation | 2 | 0.008 |
Negative regulation of lipid storage | 2 | 0.008 |
Immune response | 4 | 0.008 |
Positive regulation of ubiquitin-protein ligase activity | 2 | 0.009 |
Positive regulation of chemokine biosynthetic process | 2 | 0.010 |
Protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 3 | 0.010 |
Positive regulation of heterotypic cell-cell adhesion | 2 | 0.011 |
Regulation of cell proliferation | 3 | 0.015 |
Regulation of I-kB kinase/NF-kB signaling | 2 | 0.015 |
Positive regulation of membrane protein ectodomain proteolysis | 2 | 0.015 |
Positive regulation of VEGF receptor signaling pathway | 2 | 0.016 |
Negative regulation of lipid catabolic process | 2 | 0.016 |
Cell‒substrate adhesion | 2 | 0.017 |
Proteasome-mediated ubiquitin-dependent protein catabolic process | 3 | 0.018 |
Blood coagulation, intrinsic pathway | 2 | 0.018 |
Positive regulation of leukocyte chemotaxis | 2 | 0.018 |
Positive regulation of protein export from the nucleus | 2 | 0.019 |
Positive regulation of NF-kB import into the nucleus | 2 | 0.021 |
Regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 2 | 0.023 |
Positive regulation of IL-8 production | 2 | 0.026 |
Positive regulation of gene expression | 3 | 0.028 |
Positive regulation of phagocytosis | 2 | 0.029 |
Lipopolysaccharide-mediated signaling pathway | 2 | 0.032 |
Protein kinase B signaling | 2 | 0.033 |
Positive regulation of nitric oxide biosynthetic process | 2 | 0.043 |
Positive regulation of IL-6 production | 2 | 0.045 |
Positive regulation of IFN-γ production | 2 | 0.046 |
Positive regulation of cell division | 2 | 0.047 |
Cellular component | ||
Platelet alpha granule lumen | 5 | 1.72E-07 |
Cell surface | 5 | 0.001 |
Extracellular region | 7 | 0.002 |
Kinetochore | 3 | 0.003 |
Extracellular space | 6 | 0.006 |
Membrane | 7 | 0.012 |
Platelet alpha granule membrane | 2 | 0.012 |
Spindle mid-zone | 2 | 0.018 |
Anaphase-promoting complex | 2 | 0.021 |
Cytosol | 8 | 0.023 |
ER to Golgi transport vesicle | 2 | 0.024 |
Integrin complex | 2 | 0.025 |
Integral component of plasma membrane | 5 | 0.038 |
Spindle microtubule | 2 | 0.040 |
Cytoplasmic microtubule | 2 | 0.047 |
Molecular function | ||
Protein binding | 16 | 0.002 |
Protease binding | 3 | 0.005 |
Identical protein binding | 5 | 0.006 |
Extracellular matrix binding | 2 | 0.026 |
Enzyme binding | 3 | 0.043 |
Chemokine activity | 2 | 0.048 |
KEGG pathway | ||
Hematopoietic cell lineage | 5 | 1.09E-05 |
ECM‒receptor interaction | 4 | 3.96E-04 |
Platelet activation | 4 | 0.001 |
Cytokine‒cytokine receptor interaction | 4 | 0.008 |
Hypertrophic cardiomyopathy | 3 | 0.008 |
Dilated cardiomyopathy | 3 | 0.009 |
Osteoclast differentiation | 3 | 0.021 |
Alzheimer's disease | 3 | 0.033 |
Focal adhesion | 3 | 0.048 |
Hub genes identified in PPI network were used for GO enrichment and pathway analyses using DAVID database.
Abbreviations: ECM, extracellular matrix; ER, endoplasmic reticulum; GO, gene ontology; KEGG, Kyoto Encyclopedia of Genes and Genomes; PPI, protein‒protein interaction.